Component
Caffeine-derived urinary enzyme-phenotyping ratios
Study-scoped entity; inspect species, exposure, model and limitations on each claim.
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
The NAT2 ratio AFMU/1MX fell to 56.7%, an alternative combined-metabolite NAT2 ratio stayed constant, and a CYP1A2 ratio transiently rose to 167%.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Same 21-person caffeine-phenotyping study.
- limitations
- Changed ratios do not prove corresponding changes in NAT2 or CYP1A2 catalytic activity.
- nutrient_topic
- Caffeine collection; salts, coffee, species and coexposure contexts retain their identities. · Caffeine
- plain_language
- A downstream block can make another enzyme’s probe result misleading.
- primary_references
- Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10027663/ · DOI 10.1007/s002280050569
Caffeine: receptors, metabolism, nutrient interactions, adaptation and discovery questions (2026-09-18) · lines 244–250
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Same 21-person caffeine-phenotyping study. · source_derived_draft · unverified_draft
## caf-probe-confounding A downstream block can make another enzyme’s probe result misleading. The NAT2 ratio AFMU/1MX fell to 56.7%, an alternative combined-metabolite NAT2 ratio stayed constant, and a CYP1A2 ratio transiently rose to 167%. Model: Same 21-person caffeine-phenotyping study. Limitations: Changed ratios do not prove corresponding changes in NAT2 or CYP1A2 catalytic activity. Evidence access: Primary abstract Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10027663/ · DOI 10.1007/s002280050569
Complete structured claim and evidenceIn 21 participants, allopurinol reduced urinary 1-methyluric-acid/1-methylxanthine to 15.9% of baseline.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- 200 mg caffeine tests during allopurinol 300 mg/day for eight days.
- limitations
- The ratio is a context-dependent probe, not a direct measurement of dietary molybdenum.
- nutrient_topic
- Caffeine collection; salts, coffee, species and coexposure contexts retain their identities. · Caffeine
- plain_language
- Blocking a downstream enzyme changed the metabolite pattern.
- primary_references
- Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10027663/ · DOI 10.1007/s002280050569
Caffeine: receptors, metabolism, nutrient interactions, adaptation and discovery questions (2026-09-18) · lines 236–242
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · 200 mg caffeine tests during allopurinol 300 mg/day for eight days. · source_derived_draft · unverified_draft
## caf-xor-ratio Blocking a downstream enzyme changed the metabolite pattern. In 21 participants, allopurinol reduced urinary 1-methyluric-acid/1-methylxanthine to 15.9% of baseline. Model: 200 mg caffeine tests during allopurinol 300 mg/day for eight days. Limitations: The ratio is a context-dependent probe, not a direct measurement of dietary molybdenum. Evidence access: Primary abstract Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10027663/ · DOI 10.1007/s002280050569
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.